BAKU. Nov 5 (Interfax) - CJSC Azerbaijan Caspian Shipping Company (ASCO) plans to decommission 65 outdated vessels by 2028 and begin transitioning to using methanol-powered and electric-powered ...

ASCO 2024 marked the 10 th anniversary of checkpoint inhibitors, which powerfully changed the nature of cancer immunotherapy. But there are still many cancers where this class of drugs doesn’t work.

Today, we are relying on digital technologies to innovate in the supply of medicines, while maintaining the most rigorous quality standards. In our sector, the use of AI and data-driven tools is ...

Private companies launch satellites weekly at a fraction of historical costs. Now these technologies aren't just viable -- they're building billion-dollar businesses. The company's rollout of ...

The first phase covers the years 2024-2027. During this phase, 65 obsolete and inefficient vessels with a total deadweight of ...

Operator Good morning, and welcome to the General Dynamics third quarter 2024 earnings conference call. [Operator ...

These technologies all have staying power. They will affect the economy and our politics, improve medicine, or influence our culture. Some are unfolding now; others will take a decade or more to ...

The goal of this internal strategy is to define how the United Nations system will support the use of new technologies like artificial intelligence, biotechnology, blockchain, and robotics to ...

Solar farms in orbit, nuclear power on the moon, space elevators and interstellar travel — which might we see happen first? World Space Week this year, which runs between Oct. 4 and Oct. 10,is ...

Leverage available technologies and content types to provide an exceptional and seamless user experience within the ASCO family of JCO journals. Advance a positive impact on cancer prevention, ...

The findings, presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on Sunday 2 June, involved analysing blood samples from the ChemoNEAR sample collection study for ...

Katherine Van Loon, MD, MPH, has been appointed as the next editor-in-chief of JCO Global Oncology (JCO GO), an American Society of Clinical Oncology (ASCO) journal.